Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1 — Stella

Recruiting

Back to NSCLC (Non-small Cell Lung Cancer) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Australia

Royal Melbourne Hospital, Melbourne, Victoria

Key details

Sponsor

Tau Medical Australia Pty Ltd

Collaborators

Tau-MEDICAL Co., Ltd.

Enrollment target

~7 participants

Started

March 2026

Primary completion

March 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov